Showing results (81-90 of 182) with videos related to
Sort By:
Pageof 19
BJU International|December 13, 2005
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapySarah Gutman, Gregory S Merrick, Wayne M Butler, et al.BJU International|August 17, 2010
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.Brachytherapy|December 31, 2010
The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetryNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.Brachytherapy|April 6, 2004
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Erectile function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.Brachytherapy|June 9, 2015
Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trialsGregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.Urology|January 26, 2005
Influence of body mass index on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Dysuria after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.Brachytherapy|August 9, 2011
Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.Pageof 19